• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.64% Nasdaq Down 0.55%

    Mast Therapeutics, Inc. (MSTX)

    -NYSE MKT
    0.54 0.00(0.00%) May 29, 4:00PM EDT
    Add to Portfolio
    Prev Close:0.54
    Open:0.54
    Bid:0.54 x 500
    Ask:0.54 x 63700
    1y Target Est:2.38
    Beta:0.88
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:0.53 - 0.56
    52wk Range:0.40 - 0.73
    Volume:1,058,493
    Avg Vol (3m):1,356,660
    Market Cap:88.06M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MSTX

    Comparison

    Symbol% ChgMkt Cap
    MSTX 0.00%88.06M
    GSKDown 0.94%107.15B
    RHHBYUp 2.83%N/A
    SNYDown 2.26%129.20B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.23
    Quarterly EPS Est (Jun-15) :-0.06
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cel... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback